These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

147 related items for PubMed ID: 3169112

  • 1. Evaluation of two oxprenolol oral osmotic (OROS) delivery systems in patients with essential hypertension.
    McInnes GT, Brodie MJ.
    Eur J Clin Pharmacol; 1988; 34(6):605-11. PubMed ID: 3169112
    [Abstract] [Full Text] [Related]

  • 2. Exercise and resting blood pressure and heart rate changes 24 h after dosing in patients with essential hypertension receiving 16/260 oxprenolol Oros once daily.
    Müller FB, Allsopp LF, Cooper GL, Bolli P, Frei P, Glaus L, Ritz R, Bühler FR.
    Br J Clin Pharmacol; 1985; 19 Suppl 2(Suppl 2):207S-212S. PubMed ID: 4005124
    [Abstract] [Full Text] [Related]

  • 3. Concentration-effect relationships for oxprenolol in patients with essential hypertension.
    McInnes GT, Brodie MJ.
    Br J Clin Pharmacol; 1988 May; 25(5):539-45. PubMed ID: 3408634
    [Abstract] [Full Text] [Related]

  • 4. A multiple dose comparative study of the pharmacodynamic and pharmacokinetic behaviour of polymer-matrix and Oros dosage forms of oxprenolol in healthy volunteers.
    Woods KL, Jack DB, Kendall MJ, Halsey A, O'Donnell ML, Warrington SJ, John VA.
    Br J Clin Pharmacol; 1985 May; 19 Suppl 2(Suppl 2):177S-184S. PubMed ID: 4005120
    [Abstract] [Full Text] [Related]

  • 5. Twenty-four hour effects of oxprenolol Oros and atenolol on heart rate, blood pressure, exercise tolerance and perceived exertion.
    van Baak MA, Verstappen FT, Oosterhuis B.
    Eur J Clin Pharmacol; 1986 May; 30(4):399-406. PubMed ID: 3743615
    [Abstract] [Full Text] [Related]

  • 6. Single-dose pharmacokinetic and pharmacodynamic comparison of polymer-matrix (Slow Trasicor) and Oros dosage forms of oxprenolol in healthy volunteers.
    Bennett PN, Bennett J, Bradbrook I, Francis J, John VA, Rogers H, Turner P, Warrington SJ.
    Br J Clin Pharmacol; 1985 May; 19 Suppl 2(Suppl 2):171S-175S. PubMed ID: 4005119
    [Abstract] [Full Text] [Related]

  • 7. Pre-dosing plasma concentrations and beta-adrenoceptor blocking effects during repeated once daily dosing with 160 mg sustained-release propranolol (Inderal LA) and 16/260 oxprenolol Oros to healthy volunteers.
    Moppert J, Degen PH, Racine-Poon A.
    Br J Clin Pharmacol; 1985 May; 19 Suppl 2(Suppl 2):197S-201S. PubMed ID: 2988591
    [Abstract] [Full Text] [Related]

  • 8. A comparison of slow release oxprenolol with conventional oxprenolol in the treatment of hypertension.
    Resnekov EB, Havard CW.
    Eur J Clin Pharmacol; 1978 Nov 16; 14(2):77-81. PubMed ID: 363434
    [Abstract] [Full Text] [Related]

  • 9. Evaluation of oxprenolol slow release and osmotic release by exercise testing and ambulatory electrocardiographic monitoring in patients with chronic stable angina pectoris.
    Bowles MJ, Khurmi NS, O'Hara MJ, Raftery EB.
    Eur J Clin Pharmacol; 1987 Nov 16; 32(2):127-33. PubMed ID: 3556193
    [Abstract] [Full Text] [Related]

  • 10. Slow release oxprenolol in angina pectoris: study comparing oxprenolol, once daily, with propranolol, four times daily.
    Olowoyeye JO, Thadani U, Parker JO.
    Am J Cardiol; 1981 May 16; 47(5):1123-7. PubMed ID: 7223659
    [Abstract] [Full Text] [Related]

  • 11. Experience with a slow-release formulation of oxprenolol.
    Waal-Manning HJ, Spears GF.
    N Z Med J; 1978 Apr 12; 87(609):245-6. PubMed ID: 275650
    [Abstract] [Full Text] [Related]

  • 12. A comparison of slow release with conventional oxprenolol: plasma concentrations and clinical effects.
    West MJ, Kendall MJ, Mitchard M, Faragher EB.
    Br J Clin Pharmacol; 1976 Jun 12; 3(3):439-43. PubMed ID: 788749
    [Abstract] [Full Text] [Related]

  • 13. A comparison of the effects of the slow release formulations of metoprolol and oxprenolol in hypertension.
    Comerford MB, Besterman EM.
    Ann Clin Res; 1982 Feb 12; 14(1):27-31. PubMed ID: 7137874
    [Abstract] [Full Text] [Related]

  • 14. Comparison of pharmacokinetic profiles of single and multiple doses of a slow release Oros oxprenolol delivery system in young normotensive and elderly hypertensive subjects.
    Bradbrook ID, Babiker M, Crome P, Gillies HC, Morrison PJ, Rogers HJ, Shotton P.
    Br J Clin Pharmacol; 1986 Apr 12; 21(4):371-6. PubMed ID: 3707811
    [Abstract] [Full Text] [Related]

  • 15. Absorption and excretion of rapid and slow release oxprenolol and their effects on heart rate and blood pressure during exercise.
    Bobik A, Jennings GL, Korner PI, Ashley P, Jackman G.
    Br J Clin Pharmacol; 1979 Jun 12; 7(6):545-9. PubMed ID: 465276
    [Abstract] [Full Text] [Related]

  • 16. A comparison of single doses of bucindolol and oxprenolol in hypertensive patients.
    Webster J, Petrie JC, Robb OJ, Jamieson M, Verschueren J.
    Br J Clin Pharmacol; 1985 Oct 12; 20(4):393-400. PubMed ID: 2866786
    [Abstract] [Full Text] [Related]

  • 17. Comparison of the beta-adrenoceptor blocking activity of oxprenolol, slow release oxprenolol and a combined oxprenolol diuretic preparation.
    Kerr MJ, Harron DW, Kinney C, Shanks RG.
    Br J Clin Pharmacol; 1981 Dec 12; 12(6):869-71. PubMed ID: 6122463
    [Abstract] [Full Text] [Related]

  • 18. Effects of oxprenolol on the intra-arterial blood pressure response to dynamic exercise in hypertensive men.
    Millar-Craig MW, Mann S, Balasubramanian V, Cashman P, Raftery EB.
    J Cardiovasc Pharmacol; 1981 Dec 12; 3(3):468-76. PubMed ID: 6168828
    [Abstract] [Full Text] [Related]

  • 19. [Comparison of the effects of oxprenolol and nifedipine on blood pressure at rest and during physical exercise in essential hypertension].
    Gambini G, Pizzuti C, Valori C.
    Clin Ter; 1988 Feb 15; 124(3):203-10. PubMed ID: 2974332
    [No Abstract] [Full Text] [Related]

  • 20. Comparative study of atenolol, metoprolol, metoprolol durules, and slow-release oxprenolol in essential hypertension.
    Wilcox RG, Hampton JR.
    Br Heart J; 1981 Nov 15; 46(5):498-502. PubMed ID: 6119103
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.